Interestingly, decreases in CD14++CD16- monocytes correlate with a positive prognostic response for patients, but whether this is because they contribute directly to disease progression or the inflammatory tone of rheumatoid arthritis is not known [63]. This evidence concerns the gene CD14 and rheumatoid arthritis.